ClinicalTrials.govpublic full text
Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke
coronary heart disease (chd), high cardiovascular risk, no prior myocardial infarction stroke, >= 50 years of age (men), >= 55 years of age (women), lipid-lowering therapy, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 898554
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.